Efficacy of Corifollitropin Alfa in Obese Women in Terms of Clinical and Molecular Parameters of IVF Success
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The aim of the present study is to determine, whether clinical efficacy of 150 mcg of
Corifollitropin alfa is the same in normal weighing and obese women. Furthermore,
investigators want to determine whether oocytes retrieved from normal weighing and obese
women, after COH using 150 mcg of Corifollitropin alfa, are of same quality on the molecular
level.